On Saturday, yet another attack on an Ebola treatment center in the Democratic Republic of the Congo killed 1 police officer and left health workers injured as terrified patients waited in isolation rooms, AP reported.

Ebola survivors in Liberia show a higher burden of certain health problems than a control group, according to an ongoing study published in the New England Journal of Medicine that has tracked people for 5 years.  

Mass drug administration is helping to quell infection rates of Plasmodium falciparum in the Greater Mekong Subregion. The parasite is to blame for nearly 63% of malaria deaths in South-East Asia. Andin the GMS, which includes Cambodia, Laos, Myanmar and Vietnam, it’s…

Door-to-door HIV testing and on-the-spot referrals for treatment could substantially reduce new HIV infections in southern Africa, according to the largest-ever HIV prevention trial, known as PopART. This randomized trial of the “universal test and treat” strategy involved…

HIV has reportedly been cured in a second patient, 12 years after the procedure that put the “Berlin patient” into long-term remission. Both feats involved bone marrow transplants that were intended to treat cancer, not HIV.

HIV mortality rates are declining thanks to effective medications and growing awareness of the disease. But among black women in the US, late diagnoses and unique social and health concerns still make the disease harder to manage—as women's stories attest, the Washington…

With an “almost obsessive focus on data,” a group mapping out an overhaul of Madagascar’s broken health system is hoping to avoid a common weakness of global health pilot projects: measuring impact. Tracking 860 indicators to reveal what works and what doesn’t, PIVOT wants…

The Democratic Republic of the Congo’s Butembo Ebola Treatment Center—closed after a violent attack last Wednesday—reopened Saturday, under the management of the country’s health ministry, the WHO, and UNICEF, according to the ministry’s latest situation report.  

After the UN High-level Meeting on Tuberculosis last fall, MSF sharply criticized major donor and high-donor countries for empty promises to end TB—the world’s leading infectious disease killer.  

For husband-and-wife team Myaing Myaing Nyunt and Chris Plowe, fighting malaria in Burma (Myanmar) is one part science, one part diplomacy.   Given the risk that treatment-resistant malaria in the region could spread globally, the stakes are especially high.